Name

Carmustine

Alternate Names

BiCNU
Carmustinea
DTI 015
DTI-015
DTI015
WR 139021
WR-139021
WR139021

Abbreviations

BCNU

Category

Chemotherapy

Subcategory

NSC Number

409962

Primary Site

Hodgkin Lymphoma
Multiple myeloma
Non-Hodgkin lymphoma

Histology

None

Remarks

Phase I FDA approved uses on brain tumor, Hodgkin's lymphoma, non-Hodgkin's lymphoma, multiple myeloma. Guilford Pharmaceuticals.(nitrosourea) (alkylating agent)

Coding

This drug should be coded
Glossary